Proinsulin human

未知生产厂商

生成 AI 研报

技术标识符

CAS 编号: 67422-14-4
UNII ID: D91579HJ6E

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Genetically modified bacteria stably expressing IL-10 and insulin
US 10858663 B2申请人: INTREXON ACTOBIOTICS N V优先权: 2016
CN
US
5 件公开
METHOD FOR QUANTIFYING INSULIN SECRETION CAPACITY IN HUMAN CELL
US 20260219259 A1申请人: JUNTENDO EDUCATIONAL FOUND优先权: 2023
CN
EP
US
WO
4 件公开
Treatment of diabetes with synthetic beta cells
- US 6933133 B2
  申请人: WISCONSIN ALUMNI RES FOUND优先权: 2000
  US
  4 件公开
- US 7425443 B2
  申请人: WISCONSIN ALUMNI RES FOUND优先权: 2005
  US
  2 件公开
Non-standard insulin analogues
US 9487572 B2申请人: WEISS MICHAEL A优先权: 2012
US
4 件公开
Ultra-concentrated rapid-acting insulin analogue formulations
US 9908925 B2申请人: UNIV CASE WESTERN RESERVE优先权: 2012
CN
US
3 件公开
Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
US 7045346 B2申请人: BOEHRINGER INGELHEIM PHARMA优先权: 2002
US
3 件公开
Modified nucleotide sequence encoding glucagon-like peptide-1 (GLP-1), nucleic acid construct comprising same for production of glucagon-like peptide-1 (GLP-1), human cells comprising said construct and insulin-producing constructs, and methods of use thereof
US 7829664 B2申请人: BOEHRINGER INGELHEIM INT优先权: 2007
US
3 件公开
Fragments of proinsulin c-peptide
US 2006234914 A1申请人: CREATIVE PEPTIDES SWEDEN AB优先权: 2002
US
Plasmids expressing human insulin and the preparation method for human insuling thereby
US 2006035316 A1申请人: LEE SANG-YONG优先权: 2002
US
Expression and application of transduction peptides - human insulinogen fusion protein
CN 1557954 A申请人: BEIJING RICHUDONGFANG TECHNOLO优先权: 2004
CN

药物

Proinsulin human

专利

Treatment of diabetes with synthetic beta cells